Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Non Operating Income (2018 - 2025)

Neurogene's Non Operating Income history spans 6 years, with the latest figure at $2.8 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 39.84% year-over-year to $2.8 million; the TTM value through Dec 2025 reached $13.0 million, up 73.92%, while the annual FY2025 figure was $13.0 million, 73.93% up from the prior year.
  • Non Operating Income reached $2.8 million in Q4 2025 per NGNE's latest filing, down from $2.8 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $19.3 million in Q4 2023 to a low of -$14000.0 in Q1 2023.
  • Average Non Operating Income over 3 years is $4.0 million, with a median of $2.4 million recorded in 2024.
  • The largest YoY upside for Non Operating Income was 13371.43% in 2024 against a maximum downside of 89.64% in 2024.
  • A 3-year view of Non Operating Income shows it stood at $19.3 million in 2023, then crashed by 89.64% to $2.0 million in 2024, then surged by 39.84% to $2.8 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Non Operating Income are $2.8 million (Q4 2025), $2.8 million (Q3 2025), and $4.1 million (Q2 2025).